ATE529104T1 - Idebenon zur behandlung von durch muskuläre dystrophie vermittelten atemwegserkrankungen - Google Patents

Idebenon zur behandlung von durch muskuläre dystrophie vermittelten atemwegserkrankungen

Info

Publication number: ATE529104T1
Authority: AT; Austria
Prior art keywords: idebenone; muscular dystrophy; treatment; respiratory diseases; diseases mediated
Prior art date: 2008-04-09

Application number

AT08007069T

Other languages

English (en)

Inventor

Gunnar Buyse

Thomas Meier

Original Assignee

Santhera Pharmaceuticals Ch

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-09

Filing date

2008-04-09

Publication date

2011-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39691216&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE529104(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-04-09 Application filed by Santhera Pharmaceuticals Ch filed Critical Santhera Pharmaceuticals Ch

2011-11-15 Application granted granted Critical

2011-11-15 Publication of ATE529104T1 publication Critical patent/ATE529104T1/de

Links

JGPMMRGNQUBGND-UHFFFAOYSA-N idebenone Chemical compound COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O JGPMMRGNQUBGND-UHFFFAOYSA-N 0.000 title abstract 3
229960004135 idebenone Drugs 0.000 title abstract 2
201000006938 muscular dystrophy Diseases 0.000 title abstract 2
230000000241 respiratory effect Effects 0.000 title abstract 2
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
230000001404 mediated effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

AT08007069T 2008-04-09 2008-04-09 Idebenon zur behandlung von durch muskuläre dystrophie vermittelten atemwegserkrankungen ATE529104T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP08007069A EP2108366B1 (de)	2008-04-09	2008-04-09	Idebenon zur Behandlung von durch muskuläre Dystrophie vermittelten Atemwegserkrankungen

Publications (1)

Publication Number	Publication Date
ATE529104T1 true ATE529104T1 (de)	2011-11-15

Family

ID=39691216

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT08007069T ATE529104T1 (de)	2008-04-09	2008-04-09	Idebenon zur behandlung von durch muskuläre dystrophie vermittelten atemwegserkrankungen

Country Status (17)

Country	Link
US (1)	US20110092469A1 (de)
EP (1)	EP2108366B1 (de)
JP (1)	JP2011516513A (de)
AT (1)	ATE529104T1 (de)
AU (1)	AU2009235681B2 (de)
CA (1)	CA2719440C (de)
CY (1)	CY1112313T1 (de)
DK (1)	DK2108366T3 (de)
ES (1)	ES2370607T3 (de)
HR (1)	HRP20110813T1 (de)
MX (1)	MX2010011099A (de)
NZ (1)	NZ588181A (de)
PL (1)	PL2108366T3 (de)
PT (1)	PT2108366E (de)
SI (1)	SI2108366T1 (de)
WO (1)	WO2009124693A1 (de)
ZA (1)	ZA201006905B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10806703B2 (en) *	2012-01-20	2020-10-20	Lts Lohmann Therapie-System Ag	Transmucosal administration system for a pharmaceutical drug
EP2620141A1 (de) *	2012-01-25	2013-07-31	Santhera Pharmaceuticals (Schweiz) AG	Dünnfilm-Arzneimittelabgabesystem für die transmukosale Verabreichung eines Benzochinon-Derivates
WO2014035356A1 (en) *	2012-08-31	2014-03-06	Mahmut Bilgic	Tablet formulations comprising a quinone derivative active agent
CN103040779B (zh) *	2013-01-01	2015-04-15	刘炜	用于神经系统疾病的口服固体药物组合物
NZ732507A (en) *	2013-03-15	2018-08-31	Sarepta Therapeutics Inc	Improved compositions for treating muscular dystrophy
CN109364050B (zh) *	2018-10-19	2021-02-02	大连医科大学	艾地苯醌在制备治疗肺动脉高压药物中的应用
US20220175800A1 (en) *	2019-04-12	2022-06-09	Ptc Therapeutics Inc.	Dispersible tablet composition
US20240269091A1 (en)	2021-06-07	2024-08-15	Katholieke Universiteit Leuven	Idebenone in the treatment of drug resistant epilepsy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS51128932A (en)	1975-04-30	1976-11-10	Takeda Chem Ind Ltd	Organic compounds
JPH11116470A (ja)	1997-08-12	1999-04-27	Takeda Chem Ind Ltd	イデベノン含有経皮投与製剤
AU8562998A (en)	1997-08-12	1999-03-01	Takeda Chemical Industries Ltd.	Idebenone-containing preparation for percutaneous administration
CA2272971C (en)	1998-10-29	2008-01-15	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Quinone derivatives for treating or preventing diseases associated with iron overload
EP1861080B1 (de) *	2005-03-21	2010-05-26	Santhera Pharmaceuticals (Schweiz) AG	Idebenon zur behandlung von muskeldystrophien
EP1891946A1 (de)	2006-08-14	2008-02-27	Santhera Pharmaceuticals (Schweiz) AG	Transmukosale Verabreichung von 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinon

2008
- 2008-04-09 AT AT08007069T patent/ATE529104T1/de active
- 2008-04-09 EP EP08007069A patent/EP2108366B1/de not_active Not-in-force
- 2008-04-09 DK DK08007069.1T patent/DK2108366T3/da active
- 2008-04-09 ES ES08007069T patent/ES2370607T3/es active Active
- 2008-04-09 PT PT08007069T patent/PT2108366E/pt unknown
- 2008-04-09 PL PL08007069T patent/PL2108366T3/pl unknown
- 2008-04-09 SI SI200830477T patent/SI2108366T1/sl unknown
2009
- 2009-04-03 NZ NZ588181A patent/NZ588181A/en not_active IP Right Cessation
- 2009-04-03 MX MX2010011099A patent/MX2010011099A/es active IP Right Grant
- 2009-04-03 US US12/934,089 patent/US20110092469A1/en not_active Abandoned
- 2009-04-03 AU AU2009235681A patent/AU2009235681B2/en not_active Ceased
- 2009-04-03 JP JP2011503366A patent/JP2011516513A/ja active Pending
- 2009-04-03 CA CA2719440A patent/CA2719440C/en not_active Expired - Fee Related
- 2009-04-03 WO PCT/EP2009/002478 patent/WO2009124693A1/en not_active Ceased
2010
- 2010-09-28 ZA ZA2010/06905A patent/ZA201006905B/en unknown
2011
- 2011-11-02 HR HR20110813T patent/HRP20110813T1/hr unknown
2012
- 2012-01-18 CY CY20121100068T patent/CY1112313T1/el unknown

Also Published As

Publication number	Publication date
PT2108366E (pt)	2011-11-10
HRP20110813T1 (hr)	2011-11-30
NZ588181A (en)	2011-11-25
ES2370607T3 (es)	2011-12-20
CA2719440A1 (en)	2009-10-15
EP2108366A1 (de)	2009-10-14
EP2108366B1 (de)	2011-10-19
AU2009235681A1 (en)	2009-10-15
CA2719440C (en)	2013-07-16
MX2010011099A (es)	2010-11-01
CY1112313T1 (el)	2015-12-09
PL2108366T3 (pl)	2012-03-30
JP2011516513A (ja)	2011-05-26
SI2108366T1 (sl)	2012-01-31
WO2009124693A1 (en)	2009-10-15
ZA201006905B (en)	2011-06-29
AU2009235681B2 (en)	2012-04-05
DK2108366T3 (da)	2012-01-30
US20110092469A1 (en)	2011-04-21

Similar Documents

Publication	Publication Date	Title
ATE529104T1 (de)	2011-11-15	Idebenon zur behandlung von durch muskuläre dystrophie vermittelten atemwegserkrankungen
CY1114356T1 (el)	2016-04-13	Αναστολεις του ιου της ηπατιτιδας c
EA201100748A1 (ru)	2011-10-31	Пиразиновые соединения в качестве ингибиторов фосфодиэстеразы 10
MY141003A (en)	2010-02-12	Materials and methods for treating viral infections with a cysteamine compound
EA201370208A1 (ru)	2014-06-30	Формы рифаксимина и их применение
MX2012000034A (es)	2012-02-21	Metodos para el tratamiento o la prevencion de la fatiga.
ATE525070T1 (de)	2011-10-15	Silbininkomponente zur behandlung von hepatitis
BR112012014715A2 (pt)	2018-10-09	"processo de tratamento cosmético da pele, e, conjunto cosmético"
TN2011000482A1 (en)	2013-03-27	Organic compounds and their uses
EP2135858A4 (de)	2012-02-08	Zusammensetzung zur behandlung von infektionserkrankungen
DE602008004317D1 (de)	2011-02-17	Verbindungen zur behandlung von hepatitis c
ATE447551T1 (de)	2009-11-15	Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
WO2011082245A3 (en)	2011-11-10	Metalloenzyme inhibitor compounds
MY149171A (en)	2013-07-31	Treatment and prevention of influenza
UY32715A (es)	2011-01-31	Combinaciones farmacéuticas útiles para el tratamiento del virus de la hepatitis c (vhc), usos y métodos relacionados
UY32720A (es)	2011-01-31	Combinaciones farmaceuticas utiles para el tratamiento del virus de la hepatitis c (vhc), usos y metodos relacionados
ATE537178T1 (de)	2011-12-15	Neue klasse von spiro-piperidinen zur behandlung neurodegenerativer krankheiten
DE502006007982D1 (de)	2010-11-11	Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
EA201200855A1 (ru)	2013-04-30	Модуляторы crth2
ATE452117T1 (de)	2010-01-15	Verfahren zur herstellung von cyclischen ketonen
DE502006008804D1 (de)	2011-03-10	Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen
WO2009023356A3 (en)	2009-07-30	Materials and methods for treating influenza infections
ATE527996T1 (de)	2011-10-15	Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium)propionat-orotat
WO2007053796A3 (en)	2007-11-29	Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion
ATE525073T1 (de)	2011-10-15	Verwendung von pyrimidylaminobenzamiden zur behandlung von durch modulation einer tie-2 kinase-aktivität verursachten krankheiten

Legal Events

Date

Code

Title

Description

2012-04-15

UEP

Publication of translation of european patent specification

Ref document number: 2108366

Country of ref document: EP